ArticleOrphanet journal of rare diseases2024

Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter study.

Renzo Mignani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.